8102
-
Therapeutics and Clinical Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Therapeutics and Clinical Risk Management
(2,215,704) Views
Editor in Chief Professor Garry Walsh
1178-203X
Case reportA 41-year-old man with polyarthritis and severe autonomic neuropathy
Matthew E Bourcier, Aaron I Vinik
Therapeutics and Clinical Risk Management 2008, 4:837-842
01 September 2008
Review
The use of calcium and vitamin D in the management of osteoporosis
John A Sunyecz
Therapeutics and Clinical Risk Management 2008, 4:827-836
01 September 2008
Review
Sevelamer carbonate in the treatment of hyperphosphatemia in patients with chronic kidney disease on hemodialysis
Vincenzo Savica, Domenico Santoro, Paolo Monardo, Agostino Mallamace, Guido Bellinghieri
Therapeutics and Clinical Risk Management 2008, 4:821-826
01 September 2008
Review
Clinical development of new prophylactic antimalarial drugs after the 5th Amendment to the Declaration of Helsinki
Geoffrey S Dow, Alan J Magill, Colin Ohrt
Therapeutics and Clinical Risk Management 2008, 4:803-819
01 September 2008
Review
The treatment of chronic hepatitis B: Focus on adefovir-like antivirals
Hans Ludger Tillmann
Therapeutics and Clinical Risk Management 2008, 4:797-802
01 September 2008
Review
Pegylated interferon 2a and 2b in combination with ribavirin for the treatment of chronic hepatitis C in HIV infected patients
Ravinder Dhillon, Simona Rossi, Steven K Herrine
Therapeutics and Clinical Risk Management 2008, 4:789-796
01 September 2008
Review
Review of oral oxymorphone in the management of pain
Paul Sloan
Therapeutics and Clinical Risk Management 2008, 4:777-787
01 September 2008
Review
Interleukin-6 inhibitors in the treatment of rheumatoid arthritis
Stephanie Hennigan, Arthur Kavanaugh
Therapeutics and Clinical Risk Management 2008, 4:767-775
01 September 2008
Review
Combating HIV resistance – focus on darunavir
Cécile L Tremblay
Therapeutics and Clinical Risk Management 2008, 4:759-765
01 September 2008
Review
Posaconazole in the management of refractory invasive fungal infections
Stefan Langner, Philipp B Staber, Peter Neumeister
Therapeutics and Clinical Risk Management 2008, 4:747-757
01 September 2008
Review
Using the tetravalent meningococcal polysaccharide-protein conjugate vaccine in the prevention of meningococcal disease
Sanford R Kimmel
Therapeutics and Clinical Risk Management 2008, 4:739-745
01 September 2008
Review
Fospropofol disodium injection for the sedation of patients undergoing colonoscopy
Benjamin E Levitzky, John J Vargo
Therapeutics and Clinical Risk Management 2008, 4:733-738
01 September 2008
Review
Bendamustine HCL for the treatment of relapsed indolent non-Hodgkin’s lymphoma
Rudolf Weide
Therapeutics and Clinical Risk Management 2008, 4:727-732
01 September 2008
Original Research
Availability of a remote online hemodynamic monitoring system during treatment in a private dental office for medically high-risk patients
Shinya Yamazaki, Hiroyoshi Kawaai, Shigeo Sasaki, Kazuhiro Shimamura, Hiroshi Segawa, Takahiro Saito
Therapeutics and Clinical Risk Management 2008, 4:721-726
01 September 2008
Original Research
Double-blind, randomized trial comparing efficacy and safety of continuing olanzapine versus switching to quetiapine in overweight or obese patients with schizophrenia or schizoaffective disorder
Walter Deberdt, Ilya Lipkovich, Alexandra N Heinloth, Lin Liu, Sara Kollack-Walker, et al
Therapeutics and Clinical Risk Management 2008, 4:713-720
01 September 2008
Original Research
Silent myocardial infarction in women with type II diabetes mellitus and microalbuminuria
Elmir Omerovic, Gerhard Brohall, Markus Müller, Truls Råmunddal, Göran Matejka, et al
Therapeutics and Clinical Risk Management 2008, 4:705-711
01 September 2008
Original Research
Early ischemic CT changes before thrombolysis: The influence of age and diabetes mellitus
Lars Thomassen, Ulrike Waje-Andreassen, Halvor Naess
Therapeutics and Clinical Risk Management 2008, 4:699-703
01 September 2008
Original Research
Risk stratification for arrhythmic death in an emergency department cohort: a new method of nonlinear PD2i analysis of the ECG
James E Skinner, Michael Meyer, William C Dalsey, Brian A Nester, George Ramalanjaona, et al
Therapeutics and Clinical Risk Management 2008, 4:689-697
01 September 2008
Original Research
Postoperative mortality after inpatient surgery: Incidence and risk factors
Karamarie Fecho, Anne T Lunney, Philip G Boysen, Peter Rock, Edward A Norfleet
Therapeutics and Clinical Risk Management 2008, 4:681-688
01 September 2008
Original Research
A systematic approach of tracking and reporting medication errors at a tertiary care university hospital, Karachi, Pakistan
Khurshid Khowaja, Rozmin Nizar, Rashida J Merchant, Jacqueline Dias, Irma Bustamante-Gavino, Amina Malik
Therapeutics and Clinical Risk Management 2008, 4:673-679
01 September 2008
Review
Pain treatment with high-dose, controlled-release oxycodone: an Italian perspective
Fabio Ferrarese, Gioia Becchimanzi, Massimo Bernardo, Maria Anna Conte, Angela Gioia, et al
Therapeutics and Clinical Risk Management 2008, 4:665-671
01 September 2008
- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- American Acne and Rosacea Society
The American Acne and Rosacea Society (AARS), is a 501(c)(6) non-profit organization dedicated to elevating the understanding and treatment of acne and rosacea.
